InvestorsHub Logo
Followers 56
Posts 3925
Boards Moderated 0
Alias Born 09/13/2011

Re: None

Friday, 11/30/2018 12:20:36 PM

Friday, November 30, 2018 12:20:36 PM

Post# of 330429
Folks I haven't been here to ride the ups and downs, excitement and disappointment of past years like some of you. However from my few months on the board, the events of last week seem to me at least give stark clarity to what BIEL should be doing going forward from here.

1. Continue to strengthen alliances and sales overseas.

2. Culminate a deal with Dr. Scholls if the divestiture from Bayer doesn't affect it. If it does, put our product back on the market and look for partners to do so with. Who knows, maybe CVS would be a good candidate, an approved product ready to go.

3. Work with CVS for full exposure in all stores.

4. Pursue Allay full bore.

5. Pursue approval for use by women for general pain applications full bore.

6. Continue to find new areas of possibility.


Nothing is foolproof to a sufficently talented fool !!